BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1505058)

  • 1. The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice.
    Baldwin WS; LeBlanc GA
    Chem Biol Interact; 1992 Aug; 83(2):155-69. PubMed ID: 1505058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-selective induction of cytochrome P-450-dependent activities by indole-3-carbinol-derived products: influence on covalent binding of benzo[a]pyrene to hepatic and pulmonary DNA in the rat.
    Park JY; Bjeldanes LF
    Chem Biol Interact; 1992 Aug; 83(3):235-47. PubMed ID: 1516151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of hepatic cytochrome P4501A by indole-3-carbinol: transient induction with continuous feeding in rainbow trout.
    Takahashi N; Dashwood RH; Bjeldanes LF; Bailey GS; Williams DE
    Food Chem Toxicol; 1995 Feb; 33(2):111-20. PubMed ID: 7867998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of hepatic CYP1A by indole-3-carbinol in protection against aflatoxin B1 hepatocarcinogenesis in rainbow trout.
    Takahashi N; Stresser DM; Williams DE; Bailey GS
    Food Chem Toxicol; 1995 Oct; 33(10):841-50. PubMed ID: 7590528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tamoxifen on peripubertal androgen imprinting of rat hepatic cytochrome P450 2C11, cytochrome P450 3A2, and steroid 5 alpha-reductase.
    Chang TK; Chan MM; Holsmer SL; Bandiera SM; Bellward GD
    Biochem Pharmacol; 1996 Feb; 51(3):357-68. PubMed ID: 8573203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary indole-3-carbinol on intestinal and hepatic monooxygenase, glutathione S-transferase and epoxide hydrolase activities in the rat.
    Bradfield CA; Bjeldanes LF
    Food Chem Toxicol; 1984 Dec; 22(12):977-82. PubMed ID: 6334634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts by indole-3-carbinol: dose-response studies in the rat colon.
    Xu M; Schut HA; Bjeldanes LF; Williams DE; Bailey GS; Dashwood RH
    Carcinogenesis; 1997 Nov; 18(11):2149-53. PubMed ID: 9395215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of alachlor on hepatic cytochrome P450 enzymes in rats.
    Hanioka N; Watanabe K; Yoda R; Ando M
    Drug Chem Toxicol; 2002 Feb; 25(1):25-37. PubMed ID: 11850968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of enzyme induction, electrophile-scavenging, and inhibition of aflatoxin B1 activation.
    Fong AT; Swanson HI; Dashwood RH; Williams DE; Hendricks JD; Bailey GS
    Biochem Pharmacol; 1990 Jan; 39(1):19-26. PubMed ID: 2105094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of drug-metabolising enzyme expression by condensation products of indole-3-ylcarbinol, an inducer in cruciferous vegetables.
    Vang O; Frandsen H; Hansen KT; Nielsen JB; Andersen O
    Pharmacol Toxicol; 1999 Feb; 84(2):59-65. PubMed ID: 10068148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulations of P450 mRNA in liver and mammary gland and P450 activities and metabolism of estrogen in liver by treatment of rats with indole-3-carbinol.
    Horn TL; Reichert MA; Bliss RL; Malejka-Giganti D
    Biochem Pharmacol; 2002 Aug; 64(3):393-404. PubMed ID: 12147290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
    Takahashi N; Harttig U; Williams DE; Bailey GS
    Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ivermectin on activities of cytochrome P450 isoenzymes in mouflon (Ovis musimon) and fallow deer (Dama dama).
    Skálová L; Szotáková B; Machala M; Neca J; Soucek P; Havlasová J; Wsól V; Krídová L; Kvasnicková E; Lamka J
    Chem Biol Interact; 2001 Aug; 137(2):155-67. PubMed ID: 11551531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplacental exposure to indole-3-carbinol induces sex-specific expression of CYP1A1 and CYP1B1 in the liver of Fischer 344 neonatal rats.
    Larsen-Su SA; Williams DE
    Toxicol Sci; 2001 Dec; 64(2):162-8. PubMed ID: 11719698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-methoxyindole-3-carbinol is a more efficient inducer of cytochrome P-450 1A1 in cultured cells than indol-3-carbinol.
    Stephensen PU; Bonnesen C; Schaldach C; Andersen O; Bjeldanes LF; Vang O
    Nutr Cancer; 2000; 36(1):112-21. PubMed ID: 10798223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of estradiol-2-hydroxylase and ethoxyresorufin-O-deethylase by 3-substituted indole compounds.
    Wong DC; Fong WP; Lee SS; Kong YC; Cheng KF; Stone G
    Eur J Pharmacol; 1998 Nov; 362(1):87-93. PubMed ID: 9865536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism.
    Yoshida M; Katashima S; Ando J; Tanaka T; Uematsu F; Nakae D; Maekawa A
    Carcinogenesis; 2004 Nov; 25(11):2257-64. PubMed ID: 15240508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3'-diindolylmethane and its parent compound indole-3-carbinol.
    Parkin DR; Malejka-Giganti D
    Cancer Detect Prev; 2004; 28(1):72-9. PubMed ID: 15041081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary indole-3-carbinol inhibits FMO activity and the expression of flavin-containing monooxygenase form 1 in rat liver and intestine.
    Larsen-Su S; Williams DE
    Drug Metab Dispos; 1996 Sep; 24(9):927-31. PubMed ID: 8886600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.
    Liu H; Wormke M; Safe SH; Bjeldanes LF
    J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.